Revvity | PKI - Interest Expense On Debt



Revvity reported $22.94M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Agilent USD 28M 1000K Jul/2025
Align Technology 0 0 Sep/2024
Bio Techne USD 2.01M 141K Mar/2025
Bio-Rad Laboratories USD 12.4M 400K Jun/2025
Bruker USD 15.7M 2.6M Jun/2025
Celltrion KRW 17.04B 1.34B Mar/2025
Charles River Laboratories USD 29.97M 2.08M Jun/2025
Cspc Pharmaceutical 10.38M 934K Dec/2024
Danaher USD 71M 1000K Jun/2025
Dentsply International USD 24M 1000K Jun/2025
Dianthus Therapeutics 4.44M 263K Sep/2024
Divis Laboratories Ltd 30M 20M Jun/2025
Edwards Lifesciences 15.5M 1000K Jun/2024
Exact Sciences USD 9.83M 143K Jun/2025
Hologic USD 28.9M 200K Jun/2025
Illumina USD 25M 0 Jun/2025
Intuitive Surgical 74.9M 18.8M Dec/2024
IQVIA Holdings USD 182M 17M Jun/2025
Kangmei Pharma CNY 1.67M 1.45M Mar/2025
Knight Therapeutics CAD 1.91M 369K Sep/2024
Laboratorios Farma 699K 666.2K Jun/2025
Laboratory Of America USD 57.1M 1.1M Jun/2025
Medical Developments International AUD 21K 23K Jun/2024
Mettler Toledo International USD 16.78M 126K Jun/2025
Myriad Genetics USD 800K 100K Mar/2025
Neuren Pharmaceuticals 0 0 Jun/2024
Qiagen NV USD 7.6M 311K Jun/2025
Quest Diagnostics USD 67M 5M Jun/2025
Quidel USD 42.9M 600K Jun/2025
Repligen USD 5.35M 104K Jun/2025
Revvity USD 22.94M 27K Jun/2025
Sartorius 41.4M 51.4M Jun/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Thermo Fisher Scientific USD 404M 101M Jun/2025
Tilray USD 7.77M 2.08M Nov/2024
Waters USD 14.35M 84K Jun/2025
Zz Pientze Pharmaceu 46.05M 36.5M Jun/2025